Dec. 4, 2023, 10:35 p.m. | Katyanna Quach

The Register - Software: AI + ML www.theregister.com

Startup Absci will turn to its generative AI algorithms to design synthetic protein

Pharma giant AstraZeneca has signed a $247 million deal with Ai drug creation company Absci to develop an antibody designed to fight cancer.…

absci ai algorithms algorithms astrazeneca cancer deal design generative pharma protein startup synthetic will

Software Engineer for AI Training Data (School Specific)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Python)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Tier 2)

@ G2i Inc | Remote

Data Engineer

@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US